SCHEMBL6769977

SCHEMBL6769977

CCOC(=O)C1Nc2c(Cl)cc(Br)cc2C(c2ccccc2)C1C

nearest known ligand 0.42

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 4/20 0.42
MAPK1 P28482 1/20 0.42
SMN1; SMN2 Q16637 1/20 0.42
MEN1 O00255 5/20 0.41
KMT2A Q03164 5/20 0.41
CYP1A2 P05177 2/20 0.40
CYP2C19 P33261 2/20 0.40
CYP2D6 P10635 1/20 0.40
POLB P06746 1/20 0.39
CYP2C9 P11712 1/20 0.38
TSHR P16473 1/20 0.38
AGTR1 P30556 1/20 0.37
MAPT P10636 2/20 0.36
LMNA P02545 1/20 0.36
GAA P10253 1/20 0.36
ATM Q13315 1/20 0.36
CNR1 P21554 1/20 0.36
TDP2 O95551 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6769515 0.74 ALDH1A1 (0.44) ALDH1A1MAPK1SMN1; SMN2MEN1KMT2A
SCHEMBL7431115 0.68 MEN1 (0.57) ALDH1A1MAPK1SMN1; SMN2MEN1KMT2A
SCHEMBL7431117 0.68 MEN1 (0.57) ALDH1A1MAPK1SMN1; SMN2MEN1KMT2A
SCHEMBL13218488 0.67 ALDH1A1 (0.52) ALDH1A1MAPK1SMN1; SMN2MEN1KMT2A
SCHEMBL6769669 0.67 ALDH1A1 (0.43) ALDH1A1MAPK1SMN1; SMN2MEN1KMT2A
SCHEMBL14074658 0.65 ALDH1A1 (0.46) ALDH1A1MAPK1SMN1; SMN2MEN1KMT2A
SCHEMBL6765763 0.64 ALDH1A1 (0.44) ALDH1A1MEN1KMT2ATSHRLMNA
SCHEMBL830681 0.63 TSHR (0.55) ALDH1A1MAPK1SMN1; SMN2MEN1KMT2A
SCHEMBL835776 0.63 TSHR (0.55) ALDH1A1MAPK1SMN1; SMN2MEN1KMT2A
SCHEMBL830682 0.63 TSHR (0.55) ALDH1A1MAPK1SMN1; SMN2MEN1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6699877-B2 TREATING PAIN, MIGRAINE, AND VARIOUS OTHER DISEASES GRUENENTHAL GMBH (DE) 2004-03-02 US disclosed
US-20030087926-A1 Substituted 1,2,3,4-tetrahydroquinoline-2-carboxylic acid derivatives GRUENENTHAL GMBH 2003-05-08 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20030087926-A1 Substituted 1,2,3,4-tetrahydroquinoline-2-carboxylic acid derivatives SDHA, CACNA1A, GRIN2C ALDH1A1 454/4885MAPK1 3177/4885SMN1; SMN2 614/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.